CYP3A4与咖啡因的相互作用:对多种基质结合的首次见解
1Department of Molecular Biology and Biochemistry, University of California, Irvine, California, USA.
The Journal of biological chemistry
|July 31, 2023
概括
晶体结构揭示了多个咖啡因分子如何与人体细胞染色体P450 3A4 (CYP3A4) 结合,这是一个关键的药物代谢酶. 这些发现提供了对药物相互作用和酶机制的见解.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类细胞染色体P450 3A4 (CYP3A4) 是药物代谢中的关键酶.
- 它的大型活性部位允许杂乱的基质结合和潜在的全osteric 效应.
- 由于难以结晶CYP3A4基质复合物,了解多种基质如何结合至关重要.
研究的目的:
- 确定CYP3A4.4中多重基质结合的结构基础.
- 为了阐明咖啡因分子在CYP3A4活性部位和相关区域内的排列.
- 调查对酶活性和药物相互作用的影响.
主要方法:
- 进行X射线晶体学以获得与咖啡因结合的CYP3A4的高分辨率结构.
- 用光谱分析来补充结构数据.
- 位点定向突变发生,以确认蛋白质-配体相互作用.
主要成果:
- 确定了CYP3A4的晶体结构,其中包括三个 (三元) 和六个 (二元) 咖啡因分子.
- 在活性部位,基质通道和外围部位观察到咖啡因分子.
- 确定了特定的结合模式,包括芳香堆叠和极性接触.
- 关键残留物 (R212,T224,F219) 与咖啡因结合和关联有关.
结论:
- 该研究提供了前所未有的结构洞察力,了解多种基质,如咖啡因,如何与CYP3A4.4结合.
- 观察到的结合模式表明了产品抑制和对酶周转的影响的潜在机制.
- 这些发现提高了对基于纯素的药物相互作用和CYP3A4介导的药物相互作用的理解.
相关概念视频
Enzymes
81.8K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.8K
Induced-fit Model
81.1K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
81.1K
Protein-Drug Binding: Mechanism and Kinetics
600
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
600
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Factors Affecting Protein-Drug Binding: Drug Interactions
200
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
200
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K


